Teachers Retirement System of The State of Kentucky boosted its stake in Allergan PLC. (NYSE:AGN) by 23.1% during the first quarter, Holdings Channel reports. The fund owned 365,853 shares of the company’s stock after buying an additional 68,763 shares during the period. Allergan PLC. comprises about 1.0% of Teachers Retirement System of The State of Kentucky’s portfolio, making the stock its 6th largest position. Teachers Retirement System of The State of Kentucky’s holdings in Allergan PLC. were worth $87,410,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Crestwood Advisors Group LLC purchased a new stake in Allergan PLC. during the first quarter valued at about $103,000. Feltz Wealth PLAN Inc. purchased a new stake in Allergan PLC. during the first quarter valued at about $107,000. Enterprise Financial Services Corp boosted its stake in Allergan PLC. by 62.7% in the first quarter. Enterprise Financial Services Corp now owns 462 shares of the company’s stock valued at $110,000 after buying an additional 178 shares during the last quarter. JNBA Financial Advisors boosted its stake in Allergan PLC. by 2.5% in the first quarter. JNBA Financial Advisors now owns 487 shares of the company’s stock valued at $116,000 after buying an additional 12 shares during the last quarter. Finally, Webster Bank N. A. boosted its stake in Allergan PLC. by 31.0% in the first quarter. Webster Bank N. A. now owns 520 shares of the company’s stock valued at $124,000 after buying an additional 123 shares during the last quarter. Institutional investors own 84.77% of the company’s stock.

Shares of Allergan PLC. (NYSE:AGN) traded down 1.14% during mid-day trading on Thursday, reaching $235.26. The company’s stock had a trading volume of 617,909 shares. The company has a market capitalization of $78.86 billion, a price-to-earnings ratio of 7.17 and a beta of 1.16. Allergan PLC. has a 1-year low of $184.50 and a 1-year high of $256.80. The firm’s 50 day moving average price is $246.68 and its 200-day moving average price is $238.04.

Allergan PLC. (NYSE:AGN) last announced its quarterly earnings results on Thursday, August 3rd. The company reported $4.02 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.95 by $0.07. The company had revenue of $4.01 billion for the quarter, compared to analyst estimates of $3.95 billion. Allergan PLC. had a net margin of 79.17% and a return on equity of 7.25%. Allergan PLC.’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter last year, the business earned $3.35 EPS. On average, analysts predict that Allergan PLC. will post $16.25 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, September 15th. Shareholders of record on Friday, August 18th will be issued a $0.70 dividend. The ex-dividend date is Wednesday, August 16th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.18%. Allergan PLC.’s dividend payout ratio (DPR) is presently 9.95%.

COPYRIGHT VIOLATION WARNING: This piece was published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.watchlistnews.com/teachers-retirement-system-of-the-state-of-kentucky-has-87-41-million-stake-in-allergan-plc-nyseagn/1471018.html.

Several equities research analysts recently issued reports on the company. UBS AG reiterated a “buy” rating and issued a $275.00 price objective on shares of Allergan PLC. in a report on Monday, May 15th. Vetr upgraded Allergan PLC. from a “sell” rating to a “hold” rating and set a $242.88 target price on the stock in a report on Monday, June 26th. Royal Bank Of Canada set a $284.00 target price on Allergan PLC. and gave the stock a “buy” rating in a report on Monday, June 12th. BidaskClub upgraded Allergan PLC. from a “hold” rating to a “buy” rating in a report on Saturday, June 24th. Finally, Mizuho restated a “buy” rating and set a $267.00 target price on shares of Allergan PLC. in a report on Wednesday, August 2nd. Eight investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Allergan PLC. currently has a consensus rating of “Buy” and a consensus target price of $274.49.

In other Allergan PLC. news, Director Nesli Basgoz sold 1,889 shares of Allergan PLC. stock in a transaction on Thursday, May 18th. The shares were sold at an average price of $220.45, for a total value of $416,430.05. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 0.36% of the stock is owned by company insiders.

About Allergan PLC.

Allergan, Inc is a multi-specialty healthcare company. The Company focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter (OTC) products. It discovers, develops and commercializes a range of products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets.

Want to see what other hedge funds are holding AGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allergan PLC. (NYSE:AGN).

Institutional Ownership by Quarter for Allergan PLC. (NYSE:AGN)

Receive News & Ratings for Allergan PLC. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergan PLC. and related companies with Analyst Ratings Network's FREE daily email newsletter.